Literature DB >> 3741400

Rat tissue concentrations of branched-chain 2-oxo acid dehydrogenase complex. Re-evaluation by immunoassay and bioassay.

P A Patston, J Espinal, J M Shaw, P J Randle.   

Abstract

A rabbit polyclonal antibody to purified ox kidney branched-chain oxo acid dehydrogenase complex was shown by a variety of techniques to be an antibody to the E2 (acyltransferase) component. Rocket immunoelectrophoresis showed that the antibody does not discriminate between phosphorylated (inactive) or dephosphorylated (active) complex, and the same technique is used to assay total branched-chain complex (sum of active and inactive forms) in rat liver and heart mitochondrial extracts. The values obtained in normal rats fed on normal diet were comparable with those obtained by spectrophotometric assay of the holocomplex reaction after conversion of inactive complex into active complex. The values obtained in liver mitochondria from rats fed on 0%-casein diet or starved for 48 h were comparable with those in rats fed on normal diet, whereas earlier studies using spectrophotometric assay had shown substantial decreases in rats fed on 0%-casein diet or starved for 48 h. It has been shown that conversion of inactive complex into active complex requires prolonged incubation (120 min) in the presence of ketoleucine (4-methyl-2-oxopentanoate; to inhibit branched-chain oxo acid dehydrogenase kinase) to effect complete conversion in mitochondria from rats fed on 0%-casein diet, or starved for 48 h, or made diabetic with alloxan. By this technique, total activity of the complex in rat liver mitochondria was unaffected by diet or diabetes. The effects of diet and diabetes to decrease the activity of branched-chain complex in rat liver are therefore apparently mediated wholly through inactivation of the complex by phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741400      PMCID: PMC1146704          DOI: 10.1042/bj2350429

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Resolution and reconstitution of bovine kidney branched-chain 2-oxo acid dehydrogenase complex.

Authors:  K G Cook; A P Bradford; S J Yeaman
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

3.  Purification and characterization of branched chain alpha-keto acid dehydrogenase complex of bovine kidney.

Authors:  F H Pettit; S J Yeaman; L J Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

5.  Purification of rat kidney branched-chain oxo acid dehydrogenase complex with endogenous kinase activity.

Authors:  R Odessey
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

6.  Inactivation of purified ox kidney branched-chain 2-oxoacid dehydrogenase complex by phosphorylation.

Authors:  H R Fatania; K S Lau; P J Randle
Journal:  FEBS Lett       Date:  1981-09-28       Impact factor: 4.124

7.  Inactivation of rat liver and kidney branched chain 2-oxoacid dehydrogenase complex by adenosine triphosphate.

Authors:  K S Lau; H R Fatania; P J Randle
Journal:  FEBS Lett       Date:  1981-04-06       Impact factor: 4.124

8.  Inactivation of rat heart branched-chain 2-oxoacid dehydrogenase complex by adenosine triphosphate.

Authors:  P J Parker; P J Randle
Journal:  FEBS Lett       Date:  1978-11-01       Impact factor: 4.124

9.  Activation of phosphorylated branched chain 2-oxoacid dehydrogenase complex.

Authors:  H R Fatania; K S Lau; P J Randle
Journal:  FEBS Lett       Date:  1982-10-04       Impact factor: 4.124

10.  Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in rat heart.

Authors:  P J Randle; P J England; R M Denton
Journal:  Biochem J       Date:  1970-05       Impact factor: 3.857

View more
  8 in total

1.  Glucocorticoid regulation of branched-chain alpha-ketoacid dehydrogenase E2 subunit gene expression.

Authors:  P A Costeas; J M Chinsky
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

Review 2.  The 2-oxo acid dehydrogenase complexes: recent advances.

Authors:  S J Yeaman
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

3.  Effects of insulin on the regulation of branched-chain alpha-keto acid dehydrogenase E1 alpha subunit gene expression.

Authors:  P A Costeas; J M Chinsky
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

4.  Preservation of the activity state of hepatic branched-chain 2-oxo acid dehydrogenase during the isolation of mitochondria.

Authors:  B Zhang; R Paxton; G W Goodwin; Y Shimomura; R A Harris
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

5.  Activity of branched-chain 2-oxo acid dehydrogenase complex in rat liver mitochondria and in rat liver.

Authors:  M Beggs; P J Randle
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

6.  Oxidative decarboxylation of branched-chain 2-oxo Fatty acids by higher plant peroxisomes.

Authors:  H Gerbling; B Gerhardt
Journal:  Plant Physiol       Date:  1988-09       Impact factor: 8.340

7.  Effects of low-protein diet and starvation on the activity of branched-chain 2-oxo acid dehydrogenase kinase in rat liver and heart.

Authors:  J Espinal; M Beggs; H Patel; P J Randle
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

8.  Modulation of rat skeletal muscle branched-chain alpha-keto acid dehydrogenase in vivo. Effects of dietary protein and meal consumption.

Authors:  K P Block; R P Aftring; W B Mehard; M G Buse
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.